TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN

AC T09446 XX ID T09446 XX DT 10.03.2005 (created); nvo. DT 04.07.2016 (updated); ros. CO Copyright (C), QIAGEN. XX FA c-Jun XX SY AP1; Jun; JunA; p39; p39-jun. XX OS Mammalia OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia XX IN T15601 AR; Mammalia. IN T08796 ASC-2; human, Homo sapiens. IN T10236 ATF-2; Mammalia. IN T23082 ATF-4; Mammalia. IN T31399 B-ATF; Mammalia. IN T17532 Bcl-3; Mammalia. IN T16043 BCL-6; Mammalia. IN T04074 brca1; human, Homo sapiens. IN T15204 brca1; Mammalia. IN T30879 BRD4-isoform1; human, Homo sapiens. IN T10523 c-Ets-2; human, Homo sapiens. IN T10346 c-Fos; Mammalia. IN T18005 c-MAF; Mammalia. IN T11261 c-Rel; Mammalia. IN T09410 C/EBPbeta; Mammalia. IN T15118 CBP; Mammalia. IN T23077 CHOP-10; Mammalia. IN T10201 COUP-TF1; Mammalia. IN T30181 CREBPA; Mammalia. IN T10659 Elf-1; Mammalia. IN T09225 En-1; mouse, Mus musculus. IN T08300 ER-alpha-L; human, Homo sapiens. IN T08596 ER-alpha; mouse, Mus musculus. IN T30386 Fra-1; Mammalia. IN T30385 Fra-2; Mammalia. IN T08629 GATA-4; Mammalia. IN T09354 Hex; mouse, Mus musculus. IN T10516 HIF-1alpha; Mammalia. IN T10639 HMGIY; Mammalia. IN T14354 hoxa9; mouse, Mus musculus. IN T14353 HOXC-8; mouse, Mus musculus. IN T08741 jdp2; rat, Rattus norvegicus. IN T10510 JunB; Mammalia. IN T09447 JunD; Mammalia. IN T22562 KRC; Mammalia. IN T09551 LEF-1; Mammalia. IN T13783 MafB; Mammalia. IN T13873 MITF; Mammalia. IN T11025 NFATc1; Mammalia. IN T11024 NFATc2; Mammalia. IN T14193 NR1B1; Mammalia. IN T13795 NRF-1; Mammalia. IN T13730 Nrf2; Mammalia. IN T17367 NRL; Mammalia. IN T23091 p300; Mammalia. IN T09956 PPARalpha; Mammalia. IN T25008 pRb; Mammalia. IN T00702 PU.1; mouse, Mus musculus. IN T09976 PU.1; human, Homo sapiens. IN T10429 PU.1; mouse, Mus musculus. IN T10138 SF-1; Mammalia. IN T30703 SIRT1; Mammalia. IN T09538 Smad3; Mammalia. IN T13998 Smad4; Mammalia. IN T00759 Sp1; human, Homo sapiens. IN T09269 Spi-B-isoform1; human, Homo sapiens. IN T04632 SRC-1; human, Homo sapiens. IN T08256 SRC-1A; human, Homo sapiens. IN T23076 STAT1; Mammalia. IN T14458 STAT3; Mammalia. IN T16672 STAT4; Mammalia. IN T14175 TBP; Mammalia. IN T16578 TGIF; Mammalia. IN T31844 topoisomerase-II-alpha; human, Homo sapiens. IN T22156 TSC22D3; Mammalia. IN T31896 VDR; Mammalia. XX MX M00172 V$AP1FJ_Q2. MX M00517 V$AP1_01. MX M00924 V$AP1_Q2_01. MX M00926 V$AP1_Q4_01. MX M00925 V$AP1_Q6_01. MX M03541 V$CJUN_Q6. MX M00041 V$CREBP1CJUN_01. XX BS R61330. BS R26201. BS R72663. BS R40067. BS R56603. BS R59113. BS R21386. BS R73991. BS R65058. BS R65059. BS R26772. BS R00235. BS R24701. BS R25170. BS R32960. BS R34899. BS R73907. BS R35920. BS R72918. BS R42041. BS R72631. BS R55848. BS R72678. BS R24999. BS R36017. BS R03186. BS R24500. BS R31379. BS R65079. BS R42177. BS R39484. BS R66912. BS R66913. BS R73999. BS R19598. BS R02953. BS R65788. BS R04079. BS R37213. BS R35834. BS R64548. BS R72063. BS R72066. BS R72068. BS R20827. BS R20828. BS R20829. BS R20830. BS R20831. BS R20832. BS R20767. BS R63726. BS R60235. BS R60237. BS R60238. BS R74039. BS R26861. BS R72456. BS R57060. XX DR TRANSPATH: MO000046942. DR TRANSCOMPEL: C00074. DR TRANSCOMPEL: C00079. DR TRANSCOMPEL: C00080. DR TRANSCOMPEL: C00158. DR TRANSCOMPEL: C00178. DR TRANSCOMPEL: C00195. DR TRANSCOMPEL: C00238. DR TRANSCOMPEL: C00242. DR TRANSCOMPEL: C00251. DR TRANSCOMPEL: C00268. DR TRANSCOMPEL: C00294. DR TRANSCOMPEL: C00571. DR TRANSCOMPEL: C00629. DR TRANSCOMPEL: C00636. XX RN [1]; RE0002566. RX PUBMED: 1648728. RA Schuele R., Rangarajan P., Yang N., Kliewer S., Ransone L. J., Bolado J., Verma I. M., Evans R. M. RT Retinoic acid is a negative regulator of AP-1-responsive genes RL Proc. Natl. Acad. Sci. USA 88:6092-6096 (1991). RN [2]; RE0007192. RX PUBMED: 8493100. RA Ombra M. N., Autiero M., DeLerma Barbaro A., Barretta R., Del Pozzo G., Guardiola J. RT Recognition of distinct HLA-DQA1 promoter elements by a single nuclear factor containing Jun and Fos or antigenically related proteins RL Nucleic Acids Res. 21:1811- 1818 (1993). RN [3]; RE0012673. RX PUBMED: 8654373. RA Gupta S., Barrett T., Whitmarsh A. J., Cavanagh J., Sluss H. K., Derijard B., Davis R. J. RT Selective interaction of JNK protein kinase isoforms with transcription factors RL EMBO J. 15:2760-2770 (1996). RN [4]; RE0015392. RX PUBMED: 10777532. RA Lee S. K., Kim J. H., Lee Y. C., Cheong J., Lee J. W. RT Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factor RL J. Biol. Chem. 275:12470-12474 (2000). RN [5]; RE0016069. RX PUBMED: 10871633. RA Dennler S., Prunier C., Ferrand N., Gauthier J. M., Atfi A. RT c-Jun inhibits transforming growth factor beta-mediated transcription by repressing Smad3 transcriptional activity. RL J. Biol. Chem. 275:28858-28865 (2000). RN [6]; RE0016714. RX PUBMED: 9334186. RA Basuyaux J. P., Ferreira E., Stehelin D., Buttice G. RT The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner. RL J. Biol. Chem. 272:26188-26195 (1997). RN [7]; RE0017781. RX PUBMED: 11287617. RA Kaminuma O., Deckert M., Elly C., Liu Y. C., Altman A. RT Vav-Rac1-mediated activation of the c-Jun N-terminal kinase/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the interleukin-2 gene promoter. RL Mol. Cell. Biol. 21:3126-3136 (2001). RN [8]; RE0018232. RX PUBMED: 8754832. RA Lee J. S., See R. H., Deng T., Shi Y. RT Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300. RL Mol. Cell. Biol. 16:4312-4326 (1996). RN [9]; RE0020464. RX PUBMED: 11432833. RA Wulf G. M., Ryo A., Wulf G. G., Lee S. W., Niu T., Petkova V., Lu K. P. RT Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1 RL EMBO J. 20:3459-3472 (2001). RN [10]; RE0020688. RX PUBMED: 10962033. RA Leonardi A., Chariot A., Claudio E., Cunningham K., Siebenlist U. RT CIKS, a connection to Ikappa B kinase and stress-activated protein kinase RL Proc. Natl. Acad. Sci. USA 97:10494-10499 (2000). RN [11]; RE0023220. RX PUBMED: 11274169. RA Hess J., Porte D., Munz C., Angel P. RT AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. RL J. Biol. Chem. 276:20029-20038 (2001). RN [12]; RE0023654. RX PUBMED: 12665576. RA Edelstein L. C., Lagos L., Simmons M., Tirumalai H., Gelinas C. RT NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1. RL Mol. Cell. Biol. 23:2749-2761 (2003). RN [13]; RE0024011. RX PUBMED: 10357819. RA Yie J., Merika M., Munshi N., Chen G., Thanos D. RT The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome. RL EMBO J. 18:3074-3089 (1999). RN [14]; RE0024064. RX PUBMED: 12200429. RA Jang S. I., Steinert P. M. RT Loricrin expression in cultured human keratinocytes is controlled by a complex interplay between transcription factors of the Sp1, CREB, AP1, and AP2 families. RL J. Biol. Chem. 277:42268-42279 (2002). RN [15]; RE0024478. RX PUBMED: 11157480. RA Ogihara H., Morii E., Kim D. K., Oboki K., Kitamura Y. RT Inhibitory effect of the transcription factor encoded by the mutant mi microphthalmia allele on transactivation of mouse mast cell protease 7 gene. RL Blood 97:645-651 (2001). RN [16]; RE0024908. RX PUBMED: 11956220. RA Wong W. K., Ou X. M., Chen K., Shih J. C. RT Activation of human monoamine oxidase B gene expression by a protein kinase C MAPK signal transduction pathway involves c-Jun and Egr-1. RL J. Biol. Chem. 277:22222-22230 (2002). RN [17]; RE0025300. RX PUBMED: 11867732. RA Schmidt D., Muller S. RT Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. RL Proc. Natl. Acad. Sci. USA 99:2872-2877 (2002). RN [18]; RE0025599. RX PUBMED: 9447996. RA Tavner F. J., Simpson R., Tashiro S., Favier D., Jenkins N. A., Gilbert D. J., Copeland N. G., MacMillan E. M., Lutwyche J., Keough R. A., Ishii S., Gonda T. J. RT Molecular cloning reveals that the p160 Myb-binding protein is a novel, predominantly nucleolar protein which may play a role in transactivation by Myb. RL Mol. Cell. Biol. 18:989-1002 (1998). RN [19]; RE0026080. RX PUBMED: 10594022. RA Kanamoto T., Mota M., Takeda K., Rubin L. L., Miyazono K., Ichijo H., Bazenet C. E. RT Role of apoptosis signal-regulating kinase in regulation of the c-Jun N- terminal kinase pathway and apoptosis in sympathetic neurons. RL Mol. Cell. Biol. 20:196-204 (2000). RN [20]; RE0026199. RX PUBMED: 9820557. RA Etienne S., Adamson P., Greenwood J., Strosberg A. D., Cazaubon S., Couraud P. O. RT ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. RL J. Immunol. 161:5755-61 (1998). RN [21]; RE0026264. RX PUBMED: 9443941. RA LeVan T. D., Bloom J. W., Adams D. G., Hensel J. L., Halonen M. RT Platelet-activating factor induction of activator protein-1 signaling in bronchial epithelial cells. RL Mol. Pharmacol. 53:135-40 (1998). RN [22]; RE0026797. RX PUBMED: 10542237. RA Delerive P., De Bosscher K., Besnard S., vanden Berghe W., Peters J. M., Gonzalez F. J., Fruchart J. C., Tedgui A., Haegeman G., Staels B. RT Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. RL J. Biol. Chem. 274:32048-54 (1999). RN [23]; RE0027787. RX PUBMED: 10497212. RA Na S. Y., Choi J. E., Kim H. J., Jhun B. H., Lee Y. C., Lee J. W. RT Bcl3, an IkappaB protein, stimulates activating protein-1 transactivation and cellular proliferation. RL J. Biol. Chem. 274:28491-6 (1999). RN [24]; RE0027983. RX PUBMED: 11371641. RA Pessah M., Prunier C., Marais J., Ferrand N., Mazars A., Lallemand F., Gauthier J. M., Atfi A. RT c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity. RL Proc. Natl. Acad. Sci. USA 98:6198-203 (2001). RN [25]; RE0028100. RX PUBMED: 11316804. RA Lively T. N., Ferguson H. A., Galasinski S. K., Seto A. G., Goodrich J. A. RT c-Jun binds the N terminus of human TAF(II)250 to derepress RNA polymerase II transcription in vitro. RL J. Biol. Chem. 276:25582-8 (2001). RN [26]; RE0028767. RX PUBMED: 11518798. RA Jorgensen J. S., Nilson J. H. RT AR Suppresses Transcription of the alpha Glycoprotein Hormone Subunit Gene Through Protein-Protein Interactions with cJun and Activation Transcription Factor 2. RL Mol. Endocrinol. 15:1496-504 (2001). RN [27]; RE0028980. RX PUBMED: 11073940. RA Sun W., Kesavan K., Schaefer B. C., Garrington T. P., Ware M., Johnson N. L., Gelfand E. W., Johnson G. L. RT MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway. RL J. Biol. Chem. 276:5093-100 (2001). RN [28]; RE0029083. RX PUBMED: 11756426. RA Yaar M., Zhai S., Fine R. E., Eisenhauer P. B., Arble B. L., Stewart K. B., Gilchrest B. A. RT Amyloid beta Binds Trimers as Well as Monomers of the 75-kDa Neurotrophin Receptor and Activates Receptor Signaling. RL J. Biol. Chem. 277:7720-5 (2002). RN [29]; RE0029294. RX PUBMED: 11698415. RA Balasubramanian S., Efimova T., Eckert R. L. RT Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes. RL J. Biol. Chem. 277:1828-36 (2002). RN [30]; RE0029618. RX PUBMED: 12165517. RA Vasanwala F. H., Kusam S., Toney L. M., Dent A. L. RT Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. RL J. Immunol. 169:1922-9 (2002). RN [31]; RE0029861. RX PUBMED: 12239223. RA Guo Y. S., Cheng J. Z., Jin G. F., Gutkind J. S., Hellmich M. R., Townsend C. M. Jr. RT Gastrin stimulates cyclooxygenase-2 expression in intestinal epithelial cells through multiple signaling pathways. Evidence for involvement of ERK5 kinase and transactivation of the epidermal growth factor receptor. RL J. Biol. Chem. 277:48755-63 (2002). RN [32]; RE0030125. RX PUBMED: 12615916. RA Bianchi E., Denti S., Catena R., Rossetti G., Polo S., Gasparian S., Putignano S., Rogge L., Pardi R. RT Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity. RL J. Biol. Chem. 278:19682-90 (2003). RN [33]; RE0030143. RX PUBMED: 12566447. RA Takatsuna H., Kato H., Gohda J., Akiyama T., Moriya A., Okamoto Y., Yamagata Y., Otsuka M., Umezawa K., Semba K., Inoue J. RT Identification of TIFA as an adapter protein that links tumor necrosis factor receptor-associated factor 6 (TRAF6) to interleukin-1 (IL-1) receptor-associated kinase-1 (IRAK-1) in IL-1 receptor signaling. RL J. Biol. Chem. 278:12144-50 (2003). RN [34]; RE0031549. RX PUBMED: 11477071. RA Teyssier C., Belguise K., Galtier F., Chalbos D. RT Characterization of the physical interaction between estrogen receptor alpha and JUN proteins. RL J. Biol. Chem. 276:36361-9 (2001). RN [35]; RE0031591. RX PUBMED: 12631113. RA chen Y. M., Lin S. L., Chen C. W., Chiang W. C., Tsai T. J., Hsieh B. S. RT Tumor necrosis factor-alpha stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: down-regulation by cAMP. RL Kidney Int. 63:474-86 (2003). RN [36]; RE0031980. RX PUBMED: 12659851. RA Huang J., Tu Z., Lee F. S. RT Mutations in protein kinase subdomain X differentially affect MEKK2 and MEKK1 activity. RL Biochem. Biophys. Res. Commun. 303:532-40 (2003). RN [37]; RE0032069. RX PUBMED: 7848298. RA Franklin C. C., McCulloch A. V., Kraft A. S. RT In vitro association between the Jun protein family and the general transcription factors, TBP and TFIIB. RL Biochem. J. 305:967-74 (1995). RN [38]; RE0032082. RX PUBMED: 11841562. RA Jha N., Kumar M. J., Boonplueang R., Andersen J. K. RT Glutathione decreases in dopaminergic PC12 cells interfere with the ubiquitin protein degradation pathway: relevance for Parkinson's disease? RL J. Neurochem 80:555-61 (2002). RN [39]; RE0033095. RX PUBMED: 14673133. RA Manna P. R., Eubank D. W., Stocco D. M. RT Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene. RL Mol. Endocrinol. 18:558-73 (2004). RN [40]; RE0034924. RX PUBMED: 10400627. RA Hashimoto A., Kurosaki M., Gotoh N., Shibuya M., Kurosaki T. RT Shc regulates epidermal growth factor-induced activation of the JNK signaling pathway. RL J. Biol. Chem. 274:20139-43 (1999). RN [41]; RE0035654. RX PUBMED: 15798216. RA Leaner V. D., Donninger H., Ellis C. A., Clark G. J., Birrer M. J. RT p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells. RL Mol. Cell. Biol. 25:3324-3337 (2005). RN [42]; RE0035864. RX PUBMED: 12121974. RA Pan Z. Z., Bruening W., Giasson B. I., Lee V. M., Godwin A. K. RT Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways. RL J. Biol. Chem. 277:35050-35060 (2002). RN [43]; RE0035966. RX PUBMED: 8710853. RA Wang W., Chevray P. M., Nathans D. RT Mammalian Sug1 and c-Fos in the nuclear 26S proteasome. RL Proc. Natl. Acad. Sci. USA 93:8236-8240 (1996). RN [44]; RE0036112. RX PUBMED: 10866655. RA Kharbanda S., Pandey P., Yamauchi T., Kumar S., Kaneki M., Kumar V., Bharti A., Yuan Z. M., Ghanem L., Rana A., Weichselbaum R., Johnson G., Kufe D. RT Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage. RL Mol. Cell. Biol. 20:4979-4989 (2000). RN [45]; RE0036810. RX PUBMED: 12874243. RA Jensen L. E., Whitehead A. S. RT Pellino3, a novel member of the Pellino protein family, promotes activation of c-Jun and Elk-1 and may act as a scaffolding protein RL J. Immunol. 171:1500-6 (2003). RN [46]; RE0037747. RX PUBMED: 11313943. RA Cohen S. B., Waha A., Gelman I. H., Vogt P. K. RT Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts RL Oncogene 20:141-6 (2001). RN [47]; RE0037761. RX PUBMED: 11254551. RA Chan E. D., Morris K. R., Belisle J. T., Hill P., Remigio L. K., Brennan P. J., Riches D. W. RT Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways RL Infect. Immun. 69:2001-10 (2001). RN [48]; RE0037796. RX PUBMED: 7615158. RA Mackman N. RT Regulation of the tissue factor gene RL FASEB J. 9:883-9 (1995). RN [49]; RE0037970. RX PUBMED: 12914529. RA Nandy A., Jenatschke S., Hartung B., Milde-Langosch K., Bamberger A. M., Gellersen B. RT Genomic structure and transcriptional regulation of the human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene RL J. Mol. Endocrinol. 31:105-21 (2003). RN [50]; RE0037971. RX PUBMED: 12077349. RA Kotaja N., Karvonen U., Janne O. A., Palvimo J. J. RT PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases RL Mol. Cell. Biol. 22:5222-34 (2002). RN [51]; RE0038457. RX PUBMED: 12667961. RA Hattori Y., Matsumura M., Kasai K. RT Vascular smooth muscle cell activation by C-reactive protein RL Cardiovasc. Res. 58:186-95 (2003). RN [52]; RE0038508. RX PUBMED: 10098852. RA Chung K. C., Park J. H., Kim C. H., Ahn Y. S. RT Tumor necrosis factor-alpha and phorbol 12-myristate 13-acetate differentially modulate cytotoxic effect of nitric oxide generated by serum deprivation in neuronal PC12 cells RL J. Neurochem 72:1482-8 (1999). RN [53]; RE0038522. RX PUBMED: 11823437. RA Westermarck J., Weiss C., Saffrich R., Kast J., Musti A. M., Wessely M., Ansorge W., Seraphin B., Wilm M., Valdez B. C., Bohmann D. RT The DEXD/H-box RNA helicase RHII/Gu is a co-factor for c-Jun-activated transcription RL EMBO J. 21:451-60 (2002). RN [54]; RE0038687. RX PUBMED: 7588318. RA Nolan E. M., Cheung T. C., Burton D. W., Deftos L. J. RT Identification and characterization of a neuroendocrine-specific 5'-regulatory region of the human chromogranin A gene RL Endocrinology 136:5632-8 (1995). RN [55]; RE0038866. RX PUBMED: 10581407. RA Gillardon F., Spranger M., Tiesler C., Hossmann K. A. RT Expression of cell death-associated phospho-c-Jun and p53-activated gene 608 in hippocampal CA1 neurons following global ischemia RL Mol. Brain Res. 73:138-43 (1999). RN [56]; RE0039097. RX PUBMED: 12554755. RA Teyssier C., Belguise K., Galtier F., Cavailles V., Chalbos D. RT Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect RL Mol. Endocrinol. 17:287-99 (2003). RN [57]; RE0039522. RX PUBMED: 14530285. RA Yang H., Sadda M. R., Yu V., Zeng Y., Lee T. D., Ou X., Chen L., Lu S. C. RT Induction of human methionine adenosyltransferase 2A expression by tumor necrosis factor alpha. Role of NF-kappa B and AP-1 RL J. Biol. Chem. 278:50887-96 (2003). RN [58]; RE0039591. RX PUBMED: 10799319. RA Huang Y., Deng T., Winston B. W. RT Characterization of hPRP4 kinase activation: potential role in signaling RL Biochem. Biophys. Res. Commun. 271:456-63 (2000). RN [59]; RE0039705. RX PUBMED: 10026157. RA Nishitani J., Nishinaka T., Cheng C. H., Rong W., Yokoyama K. K., Chiu R. RT Recruitment of the retinoblastoma protein to c-Jun enhances transcription activity mediated through the AP-1 binding site RL J. Biol. Chem. 274:5454-61 (1999). RN [60]; RE0039869. RX PUBMED: 12177049. RA Kannan-Thulasiraman P., Shapiro D. J. RT Modulators of inflammation use nuclear factor-kappa B and activator protein-1 sites to induce the caspase-1 and granzyme B inhibitor, proteinase inhibitor 9 RL J. Biol. Chem. 277:41230-9 (2002). RN [61]; RE0039880. RX PUBMED: 12622720. RA Wu L., Tanimoto A., Murata Y., Sasaguri T., Fan J., Sasaguri Y., Watanabe T. RT Matrix metalloproteinase-12 gene expression in human vascular smooth muscle cells RL Genes Cells 8:225-34 (2003). RN [62]; RE0040044. RX PUBMED: 11579135. RA Saitoh T., Tanaka S., Koike T. RT Rapid induction and Ca(2+) influx-mediated suppression of vitamin D3 up-regulated protein 1 (VDUP1) mRNA in cerebellar granule neurons undergoing apoptosis RL J. Neurochem 78:1267-76 (2001). RN [63]; RE0040351. RX PUBMED: 12149257. RA Lafont J., Laurent M., Thibout H., Lallemand F., Le Bouc Y., Atfi A., Martinerie C. RT The expression of novH in adrenocortical cells is down-regulated by TGFbeta 1 through c-Jun in a Smad-independent manner RL J. Biol. Chem. 277:41220-9 (2002). RN [64]; RE0040417. RX PUBMED: 14682477. RA Liang M., Liao E. Y., Xu X., Luo X. H., Xiao X. H. RT Effects of progesterone and 18-methyl levonorgestrel on osteoblastic cells RL Endocr. Res. 29:483-501 (2003). RN [65]; RE0040649. RX PUBMED: 15249231. RA Huang C., Wang Y., Li D., Li Y., Luo J., Yuan W., Ou Y., Zhu C., Zhang Y., Wang Z., Liu M., Wu X. RT Inhibition of transcriptional activities of AP-1 and c-Jun by a new zinc finger protein ZNF394 RL Biochem. Biophys. Res. Commun. 320:1298-305 (2004). RN [66]; RE0040673. RX PUBMED: 10788448. RA Li S., Liu X., Ascoli M. RT p38JAB1 binds to the intracellular precursor of the lutropin/choriogonadotropin receptor and promotes its degradation RL J. Biol. Chem. 275:13386-93 (2000). RN [67]; RE0040733. RX PUBMED: 10657480. RA Redburn J. L., Leah J. D. RT The induction and potentiation of c-Jun and c-Fos expression in spinal neurons mediated by NK1 and NK2 receptors RL Neuropeptides 33:115-9 (1999). RN [68]; RE0041162. RX PUBMED: 12700665. RA Zada A. A., Singh S. M., Reddy V. A., Elsasser A., Meisel A., Haferlach T., Tenen D. G., Hiddemann W., Behre G. RT Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation RL Oncogene 22:2296-308 (2003). RN [69]; RE0041198. RX PUBMED: 10725330. RA Aho S., Buisson M., Pajunen T., Ryoo Y. W., Giot J. F., Gruffat H., Sergeant A., Uitto J. RT Ubinuclein, a novel nuclear protein interacting with cellular and viral transcription factors RL J. Cell Biol. 148:1165-76 (2000). RN [70]; RE0041444. RX PUBMED: 11934895. RA Lin F., Kolluri S. K., Chen G. Q., Zhang X. K. RT Regulation of retinoic acid-induced inhibition of AP-1 activity by orphan receptor chicken ovalbumin upstream promoter-transcription factor RL J. Biol. Chem. 277:21414-22 (2002). RN [71]; RE0041687. RX PUBMED: 12077347. RA Jung D. J., Sung H. S., Goo Y. W., Lee H. M., Park O. K., Jung S. Y., Lim J., Kim H. J., Lee S. K., Kim T. S., Lee J. W., Lee Y. C. RT Novel transcription coactivator complex containing activating signal cointegrator 1 RL Mol. Cell. Biol. 22:5203-11 (2002). RN [72]; RE0041887. RX PUBMED: 9973222. RA Kim J. Y., Sutton M. E., Lu D. J., Cho T. A., Goumnerova L. C., Goritchenko L., Kaufman J. R., Lam K. K., Billet A. L., Tarbell N. J., Wu J., Allen J. C., Stiles C. D., Segal R. A., Pomeroy S. L. RT Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas RL Cancer Res. 59:711-9 (1999). RN [73]; RE0041979. RX PUBMED: 12833146. RA Kool J., Hamdi M., Cornelissen-Steijger P., van der Eb A. J., Terleth C., van Dam H. RT Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2 RL Oncogene 22:4235-42 (2003). RN [74]; RE0042389. RX PUBMED: 9580241. RA Castellanos M. C., Munoz C., Montoya M. C., Lara-Pezzi E., Lopez-Cabrera M., de Landazuri M. O. RT Expression of the leukocyte early activation antigen CD69 is regulated by the transcription factor AP-1 RL J. Immunol. 159:5463-73 (1997). RN [75]; RE0042486. RX PUBMED: 12441106. RA Zhang S., Liu J., MacGibbon G., Dragunow M., Cooper G. J. RT Increased expression and activation of c-Jun contributes to human amylin-induced apoptosis in pancreatic islet beta-cells RL J. Mol. Biol. 324:271-85 (2002). RN [76]; RE0042601. RX PUBMED: 9799232. RA Hacker H., Mischak H., Miethke T., Liptay S., Schmid R., Sparwasser T., Heeg K., Lipford G. B., Wagner H. RT CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation RL EMBO J. 17:6230-40 (1998). RN [77]; RE0042645. RX PUBMED: 12791272. RA Zenz R., Scheuch H., Martin P., Frank C., Eferl R., Kenner L., Sibilia M., Wagner E. F. RT c-Jun regulates eyelid closure and skin tumor development through EGFR signaling RL Dev. Cell 4:879-89 (2003). RN [78]; RE0042888. RX PUBMED: 9500466. RA Sapi E., Flick M. B., Rodov S., Kacinski B. M. RT Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells RL Cancer Res. 58:1027-33 (1998). RN [79]; RE0043216. RX PUBMED: 12414794. RA Gupta P., Prywes R. RT ATF1 phosphorylation by the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression RL J. Biol. Chem. 277:50550-6 (2002). RN [80]; RE0043483. RX PUBMED: 8194525. RA Hirai S., Izumi Y., Higa K., Kaibuchi K., Mizuno K., Osada S., Suzuki K., Ohno S. RT Ras-dependent signal transduction is indispensable but not sufficient for the activation of AP1/Jun by PKC delta RL EMBO J. 13:2331-40 (1994). RN [81]; RE0043518. RX PUBMED: 11799073. RA Hattori Y., Suzuki M., Hattori S., Kasai K. RT Vascular smooth muscle cell activation by glycated albumin (Amadori adducts) RL Hypertension 39:22-8 (2002). RN [82]; RE0043769. RX PUBMED: 8114760. RA Kimura E., Sonobe M. H., Armelin M. C., Armelin H. A. RT Induction of FOS and JUN proteins by adrenocorticotropin and phorbol ester but not by 3',5'-cyclic adenosine monophosphate derivatives RL Mol. Endocrinol. 7:1463-71 (1993). RN [83]; RE0044094. RX PUBMED: 11035063. RA Hossain K., Akhand A. A., Kato M., Du J., Takeda K., Wu J., Takeuchi K., Liu W., Suzuki H., Nakashima I. RT Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase RL J. Immunol. 165:4290-7 (2000). RN [84]; RE0044873. RX PUBMED: 8798649. RA Jang S. I., Steinert P. M., Markova N. G. RT Activator protein 1 activity is involved in the regulation of the cell type-specific expression from the proximal promoter of the human profilaggrin gene RL J. Biol. Chem. 271:24105-14 (1996). RN [85]; RE0045061. RX PUBMED: 12737630. RA Marden N. Y., Fiala-Beer E., Xiang S. H., Murray M. RT Role of activator protein-1 in the down-regulation of the human CYP2J2 gene in hypoxia RL Biochem. J. 373:669-80 (2003). RN [86]; RE0045285. RX PUBMED: 11414701. RA Laderoute K. R., Calaoagan J. M., Knapp A. M., Mendonca H. L., Johnson R. S. RT c-jun cooperates with SV40 T-antigen to sustain MMP-2 expression in immortalized cells RL Biochem. Biophys. Res. Commun. 284:1134-9 (2001). RN [87]; RE0045303. RX PUBMED: 15086567. RA Gangnuss S., Cowin A. J., Daehn I. S., Hatzirodos N., Rothnagel J. A., Varelias A., Rayner T. E. RT Regulation of MAPK activation, AP-1 transcription factor expression and keratinocyte differentiation in wounded fetal skin. RL J. Invest. Dermatol 122:791-804 (2004). RN [88]; RE0045304. RX PUBMED: 14673150. RA Murphy L. O., MacKeigan J. P., Blenis J. RT A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration RL Mol. Cell. Biol. 24:144-53 (2004). RN [89]; RE0045306. RX PUBMED: 11909946. RA Laderoute K. R., Calaoagan J. M., Gustafson-Brown C., Knapp A. M., Li G. C., Mendonca H. L., Ryan H. E., Wang Z., Johnson R. S. RT The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent RL Mol. Cell. Biol. 22:2515-23 (2002). RN [90]; RE0045327. RX PUBMED: 10557095. RA Smith L. M., Wise S. C., Hendricks D. T., Sabichi A. L., Bos T., Reddy P., Brown P. H., Birrer M. J. RT cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype RL Oncogene 18:6063-70 (1999). RN [91]; RE0045718. RX PUBMED: 10974538. RA Jessen B. A., Qin Q., Rice R. H. RT Functional AP1 and CRE response elements in the human keratinocyte transglutaminase promoter mediating Whn suppression RL Gene 254:77-85 (2000). RN [92]; RE0045918. RX PUBMED: 14996741. RA Lee C. M., Lo H. W., Shao R. P., Wang S. C., Xia W., Gershenson D. M., Hung M. C. RT Selective activation of ceruloplasmin promoter in ovarian tumors: potential use for gene therapy RL Cancer Res. 64:1788-93 (2004). RN [93]; RE0046275. RX PUBMED: 11279250. RA Schmitz U., Thommes K., Beier I., Wagner W., Sachinidis A., Dusing R., Vetter H. RT Angiotensin II-induced stimulation of p21-activated kinase and c-Jun NH2-terminal kinase is mediated by Rac1 and Nck RL J. Biol. Chem. 276:22003-10 (2001). RN [94]; RE0046416. RX PUBMED: 10692442. RA Sakakibara A., Hattori S. RT Chat, a Cas/HEF1-associated adaptor protein that integrates multiple signaling pathways RL J. Biol. Chem. 275:6404-10 (2000). RN [95]; RE0046559. RX PUBMED: 11397794. RA Mittelstadt P. R., Ashwell J. D. RT Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ RL J. Biol. Chem. 276:29603-10 (2001). RN [96]; RE0046567. RX PUBMED: 10022583. RA Chen S., Mantei N., Dong L., Schachner M. RT Prevention of neuronal cell death by neural adhesion molecules L1 and CHL1 RL J. Neurobiol. 38:428-39 (1999). RN [97]; RE0046794. RX PUBMED: 11756552. RA Dan C., Nath N., Liberto M., Minden A. RT PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells RL Mol. Cell. Biol. 22:567-77 (2002). RN [98]; RE0046985. RX PUBMED: 15358865. RA Gao M., Labuda T., Xia Y., Gallagher E., Fang D., Liu Y. C., Karin M. RT Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch RL Science 306:271-5 (2004). RN [99]; RE0047040. RX PUBMED: 15087382. RA Brellier F., Marionnet C., Chevallier-Lagente O., Toftgard R., Mauviel A., Sarasin A., Magnaldo T. RT Ultraviolet irradiation represses PATCHED gene transcription in human epidermal keratinocytes through an activator protein-1-dependent process RL Cancer Res. 64:2699-704 (2004). RN [100]; RE0047247. RX PUBMED: 10918598. RA Su Z., Shi Y., Fisher P. B. RT Cooperation between AP1 and PEA3 sites within the progression elevated gene-3 (PEG-3) promoter regulate basal and differential expression of PEG-3 during progression of the oncogenic phenotype in transformed rat embryo cells RL Oncogene 19:3411-21 (2000). RN [101]; RE0047321. RX PUBMED: 10788439. RA Muller S., Berger M., Lehembre F., Seeler J. S., haupt Y., Dejean A. RT c-Jun and p53 activity is modulated by SUMO-1 modification. RL J. Biol. Chem. 275:13321-13329 (2000). RN [102]; RE0047363. RX PUBMED: 9642216. RA Lee S. K., Kim H. J., Na S. Y., Kim T. S., Choi H. S., Im S. Y., Lee J. W. RT Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits. RL J. Biol. Chem. 273:16651-16654 (1998). RN [103]; RE0047473. RX PUBMED: 9988737. RA Behre G., Whitmarsh A. J., Coghlan M. P., Hoang T., Carpenter C. L., Zhang D. E., Davis R. J., Tenen D. G. RT c-Jun is a JNK-independent coactivator of the PU.1 transcription factor. RL J. Biol. Chem. 274:4939-4946 (1999). RN [104]; RE0047476. RX PUBMED: 12101239. RA Wardell S. E., Boonyaratanakornkit V., Adelman J. S., Aronheim A., Edwards D. P. RT Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator. RL Mol. Cell. Biol. 22:5451-5466 (2002). RN [105]; RE0047500. RX PUBMED: 11099046. RA Lanzetti L., Rybin V., Malabarba M. G., Christoforidis S., Scita G., Zerial M., Di Fiore P. P. RT The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5. RL Nature 408:374-377 (2000). RN [106]; RE0047533. RX PUBMED: 10523647. RA Ubeda M., Vallejo M., Habener J. F. RT CHOP enhancement of gene transcription by interactions with Jun/Fos AP-1 complex proteins. RL Mol. Cell. Biol. 19:7589-7599 (1999). RN [107]; RE0047551. RX PUBMED: 14707112. RA Oukka M., Wein M. N., Glimcher L. H. RT Schnurri-3 (KRC) interacts with c-Jun to regulate the IL-2 gene in T cells. RL J. Exp. Med. 199:15-24 (2004). RN [108]; RE0047738. RX PUBMED: 15894542. RA Hocevar B. A., Prunier C., Howe P. H. RT Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway. RL J. Biol. Chem. 280:25920-25927 (2005). RN [109]; RE0047797. RX PUBMED: 15923621. RA Mialon A., Sankinen M., Soderstrom H., Junttila T. T., Holmstrom T., Koivusalo R., Papageorgiou A. C., Johnson R. S., Hietanen S., Elenius K., Westermarck J. RT DNA topoisomerase I is a cofactor for c-Jun in the regulation of epidermal growth factor receptor expression and cancer cell proliferation. RL Mol. Cell. Biol. 25:5040-5051 (2005). RN [110]; RE0047810. RX PUBMED: 14701856. RA Debril M. B., Gelman L., Fayard E., Annicotte J. S., Rocchi S., Auwerx J. RT Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit. RL J. Biol. Chem. 279:16677-16686 (2004). RN [111]; RE0047851. RX PUBMED: 10847592. RA Lee S. K., Na S. Y., Jung S. Y., Choi J. E., Jhun B. H., Cheong J., Meltzer P. S., Lee Y. C., Lee J. W. RT Activating protein-1, nuclear factor-kappaB, and serum response factor as novel target molecules of the cancer-amplified transcription coactivator ASC-2. RL Mol. Endocrinol. 14:915-925 (2000). RN [112]; RE0047941. RX PUBMED: 8387155. RA Kroll D. J., Sullivan D. M., Gutierrez-Hartmann A., Hoeffler J. P. RT Modification of DNA topoisomerase II activity via direct interactions with the cyclic adenosine-3',5'-monophosphate response element-binding protein and related transcription factors. RL Mol. Endocrinol. 7:305-318 (1993). RN [113]; RE0048037. RX PUBMED: 12080089. RA Hu Y. F., Li R. RT JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction. RL Genes Dev. 16:1509-1517 (2002). RN [114]; RE0048039. RX PUBMED: 12052834. RA Yazgan O., Pfarr C. M. RT Regulation of two JunD isoforms by Jun N-terminal kinases. RL J. Biol. Chem. 277:29710-29718 (2002). RN [115]; RE0048067. RX PUBMED: 16157600. RA Abell A. N., Johnson G. L. RT MEKK4 is an effector of the embryonic TRAF4 for JNK activation. RL J. Biol. Chem. 280:35793-35796 (2005). RN [116]; RE0048088. RX PUBMED: 8945519. RA Kallunki T., Deng T., Hibi M., Karin M. RT c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. RL Cell 87:929-939 (1996). RN [117]; RE0048127. RX PUBMED: 10411939. RA Zhang P., Behre G., Pan J., Iwama A., Wara-Aswapati N., Radomska H. S., Auron P. E., Tenen D. G., Sun Z. RT Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. RL Proc. Natl. Acad. Sci. USA 96:8705-8710 (1999). RN [118]; RE0048196. RX PUBMED: 10421840. RA Miyata Y., Akashi M., Nishida E. RT Molecular cloning and characterization of a novel member of the MAP kinase superfamily. RL Genes Cells 4:299-309 (1999). RN [119]; RE0048238. RX PUBMED: 11027273. RA Smith J. L., Schaffner A. E., Hofmeister J. K., Hartman M., Wei G., Forsthoefel D., Hume D. A., Ostrowski M. C. RT ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice. RL Mol. Cell. Biol. 20:8026-8034 (2000). RN [120]; RE0048336. RX PUBMED: 15637062. RA Denis F. M., Benecke A., Di Gioia Y., Touw I. P., Cayre Y. E., Lutz P. G. RT PRAM-1 potentiates arsenic trioxide-induced JNK activation. RL J. Biol. Chem. 280:9043-9048 (2005). RN [121]; RE0048349. RX PUBMED: 11356826. RA Hong S., Park S. J., Kong H. J., Shuman J. D., Cheong J. RT Functional interaction of bZIP proteins and the large subunit of replication factor C in liver and adipose cells. RL J. Biol. Chem. 276:28098-28105 (2001). RN [122]; RE0049164. RX PUBMED: 15701643. RA Cheng J., Perkins N. D., Yeh E. T. RT Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases. RL J. Biol. Chem. 280:14492-14498 (2005). RN [123]; RE0049265. RX PUBMED: 16142216. RA Lee Y. S., Jang M. S., Lee J. S., Choi E. J., Kim E. RT SUMO-1 represses apoptosis signal-regulating kinase 1 activation through physical interaction and not through covalent modification. RL EMBO Rep. 6:949-955 (2005). RN [124]; RE0049372. RX PUBMED: 11336543. RA Zhu N., Ware C. F., Lai M. M. RT Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor. RL Virology 283:178-187 (2001). RN [125]; RE0049520. RX PUBMED: 11432804. RA Chen C. Y., Juo P., Liou J. S., Li C. Q., Yu Q., Blenis J., Faller D. V. RT The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis. RL Cell Growth Differ. 12:297-306 (2001). RN [126]; RE0050105. RX PUBMED: 15229651. RA Alahari S. K., Reddig P. J., Juliano R. L. RT The integrin-binding protein Nischarin regulates cell migration by inhibiting PAK. RL EMBO J. 23:2777-2788 (2004). RN [127]; RE0050427. RX PUBMED: 9079650. RA Gerwins P., Blank J. L., Johnson G. L. RT Cloning of a novel mitogen-activated protein kinase kinase kinase, MEKK4, that selectively regulates the c-Jun amino terminal kinase pathway. RL J. Biol. Chem. 272:8288-8295 (1997). RN [128]; RE0051515. RX PUBMED: 17158449. RA Besse A., Lamothe B., Campos A. D., Webster W. K., Maddineni U., Lin S. C., Wu H., Darnay B. G. RT TAK1-dependent signaling requires functional interaction with TAB2/TAB3. RL J. Biol. Chem. 282:3918-3928 (2007). RN [129]; RE0052166. RX PUBMED: 9427647. RA May G. H., Funk M., Black E. J., Clark W., Hussain S., Woodgett J. R., Gillespie D. A. RT An oncogenic mutation uncouples the v-Jun oncoprotein from positive regulation by the SAPK/JNK pathway in vivo. RL Curr. Biol. 8:117-120 (1998). RN [130]; RE0052373. RX PUBMED: 17178890. RA Zerbini L. F., Czibere A., Wang Y., Correa R. G., Otu H., Joseph M., Takayasu Y., Silver M., Gu X., Ruchusatsawat K., Li L., Sarkar D., Zhou J. R., Fisher P. B., Libermann T. A. RT A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cells. RL Cancer Res. 66:11922-11931 (2006). RN [131]; RE0052694. RX PUBMED: 11551904. RA Schaefer L. K., Wang S., Schaefer T. S. RT Functional interaction of Jun and homeodomain proteins. RL J. Biol. Chem. 276:43074-43082 (2001). RN [132]; RE0053346. RX PUBMED: 9547236. RA Yoon S. O., Casaccia-Bonnefil P., Carter B., Chao M. V. RT Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. RL J. Neurosci. 18:3273-3281 (1998). RN [133]; RE0053627. RX PUBMED: 11075819. RA Lee H., Jiang F., Wang Q., Nicosia S. V., Yang J., Su B., Bai W. RT MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells. RL Mol. Endocrinol. 14:1882-1896 (2000). RN [134]; RE0053674. RX PUBMED: 16818236. RA Lu C., Zhu F., Cho Y. Y., Tang F., Zykova T., Ma W. Y., Bode A. M., Dong Z. RT Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. RL Mol. Cell 23:121-132 (2006). RN [135]; RE0053686. RX PUBMED: 15743761. RA Nishida M., Tanabe S., Maruyama Y., Mangmool S., Urayama K., Nagamatsu Y., Takagahara S., Turner J. H., Kozasa T., Kobayashi H., Sato Y., Kawanishi T., Inoue R., Nagao T., Kurose H. RT G alpha 12/13- and reactive oxygen species-dependent activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes. RL J. Biol. Chem. 280:18434-18441 (2005). RN [136]; RE0054081. RX PUBMED: 16679312. RA Huang Y., Keen J. C., Pledgie A., Marton L. J., Zhu T., Sukumar S., Park B. H., Blair B., Brenner K., Casero RA J. r., Davidson N. E. RT Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cells. RL J. Biol. Chem. 281:19055-19063 (2006). RN [137]; RE0054209. RX PUBMED: 14551246. RA Izumiya Y., Kim S., Izumi Y., Yoshida K., Yoshiyama M., Matsuzawa A., Ichijo H., Iwao H. RT Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling. RL Circ. Res. 93:874-883 (2003). RN [138]; RE0054254. RX PUBMED: 9648723. RA Schmitz U., Ishida T., Ishida M., Surapisitchat J., Hasham M. I., Pelech S., Berk B. C. RT Angiotensin II stimulates p21-activated kinase in vascular smooth muscle cells: role in activation of JNK. RL Circ. Res. 82:1272-1278 (1998). RN [139]; RE0054543. RX PUBMED: 17317104. RA Jamaluddin M., Wang S., Boldogh I., Tian B., Brasier A. R. RT TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. RL Cell. Signal. 19:1419-1433 (2007). RN [140]; RE0054550. RX PUBMED: 8598911. RA Verheij M., Bose R., Lin X. H., Yao B., Jarvis W. D., Grant S., Birrer M. J., Szabo E., Zon L. I., Kyriakis J. M., Haimovitz-Friedman A., Fuks Z., Kolesnick R. N. RT Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. RL Nature 380:75-79 (1996). RN [141]; RE0054705. RX PUBMED: 18342022. RA Tapias A., Ciudad C. J., Noe V. RT Transcriptional regulation of the 5'-flanking region of the human transcription factor Sp3 gene by NF-1, c-Myb, B-Myb, AP-1 and E2F. RL Biochim. Biophys. Acta 1779:318-329 (2008). RN [142]; RE0054730. RX PUBMED: 16306937. RA Hacker H., Redecke V., Blagoev B., Kratchmarova I., Hsu L. C., Wang G. G., Kamps M. P., Raz E., Wagner H., Hacker G., Mann M., Karin M. RT Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. RL Nature 439:204-207 (2006). RN [143]; RE0054772. RX PUBMED: 17689131. RA Humar M., Loop T., Schmidt R., Hoetzel A., Roesslein M., Andriopoulos N., Pahl H. L., Geiger K. K., Pannen B. H. RT The mitogen-activated protein kinase p38 regulates activator protein 1 by direct phosphorylation of c-Jun. RL Int. J. Biochem. Cell Biol. 39:2278-2288 (2007). RN [144]; RE0054902. RX PUBMED: 18222647. RA Muniyappa H., Das K. C. RT Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism. RL Cell. Signal. 20:675-683 (2008). RN [145]; RE0055018. RX PUBMED: 17273900. RA Huang Y. C., Chang W. C., Su J. G., Cai J. L., Chen C. C., Hung J. J., Liu Y. W. RT Peptidoglycan enhances transcriptional expression of CCAAT/enhancer-binding protein delta gene in mouse macrophages. RL J. Biomed. Sci. 14:407-418 (2007). RN [146]; RE0055053. RX PUBMED: 17938171. RA Ryo A., Hirai A., Nishi M., Liou Y. C., Perrem K., Lin S. C., Hirano H., Lee S. W., Aoki I. RT A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx. RL J. Biol. Chem. 282:36671-36681 (2007). RN [147]; RE0055094. RX PUBMED: 17359934. RA Waldron R. T., Whitelegge J. P., Faull K. F., Rozengurt E. RT Identification of a novel phosphorylation site in c-jun directly targeted in vitro by protein kinase D. RL Biochem. Biophys. Res. Commun. 356:361-367 (2007). RN [148]; RE0055134. RX PUBMED: 17804415. RA Wang L., Dai W., Lu L. RT Stress-induced c-Jun activation mediated by Polo-like kinase 3 in corneal epithelial cells. RL J. Biol. Chem. 282:32121-32127 (2007). RN [149]; RE0055365. RX PUBMED: 16924232. RA Takada Y., Ichikawa H., Pataer A., Swisher S., Aggarwal B. B. RT Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation. RL Oncogene 26:1201-1212 (2007). RN [150]; RE0055754. RX PUBMED: 12824049. RA Lopez-Bayghen E., Espinoza-Rojo M., Ortega A. RT Glutamate down-regulates GLAST expression through AMPA receptors in Bergmann glial cells. RL Mol. Brain Res. 115:1-9 (2003). RN [151]; RE0055798. RX PUBMED: 19164283. RA Gao S. Y., Li E. M., Cui L., Lu X. F., Meng L. Y., Yuan H. M., Xie J. J., Du Z. P., Pang J. X., Xu L. Y. RT Sp1 and AP-1 regulate expression of the human gene VIL2 in esophageal carcinoma cells. RL J. Biol. Chem. 284:7995-8004 (2009). RN [152]; RE0055854. RX PUBMED: 18097042. RA Marusina A. I., Burgess S. J., Pathmanathan I., Borrego F., Coligan J. E. RT Regulation of human DAP10 gene expression in NK and T cells by Ap-1 transcription factors. RL J. Immunol. 180:409-417 (2008). RN [153]; RE0062625. RX PUBMED: 18486448. RA Xie J., Onnockx S., Vandenbroere I., Degraef C., Erneux C., Pirson I. RT The docking properties of SHIP2 influence both JIP1 tyrosine phosphorylation and JNK activity. RL Cell. Signal. 20:1432-1441 (2008). RN [154]; RE0063007. RX PUBMED: 17079781. RA Pantano C., Anathy V., Ranjan P., Heintz N. H., Janssen-Heininger Y. M. RT Nonphagocytic oxidase 1 causes death in lung epithelial cells via a TNF-RI-JNK signaling axis. RL Am. J. Respir. Cell Mol. Biol. 36:473-479 (2007). RN [155]; RE0063474. RX PUBMED: 19592489. RA Liu W., Ouyang X., Yang J., Liu J., Li Q., Gu Y., Fukata M., Lin T., He C., Abreu M., Unkeless J. C., Mayer L., Xiong H. RT AP-1 activated by Toll-like receptors regulates expression of IL-23 p19. RL J. Biol. Chem. 284:24006-16 (2009). RN [156]; RE0064214. RX PUBMED: 15908180. RA Kim W. H., Lee J. W., Gao B., Jung M. H. RT Synergistic activation of JNK/SAPK induced by TNF-alpha and IFN-gamma: apoptosis of pancreatic beta-cells via the p53 and ROS pathway. RL Cell. Signal. 17:1516-1532 (2005). RN [157]; RE0065005. RX PUBMED: 18192274. RA Kiryu-Seo S., Kato R., Ogawa T., Nakagomi S., Nagata K., Kiyama H. RT Neuronal injury-inducible gene is synergistically regulated by ATF3, c-Jun, and STAT3 through the interaction with Sp1 in damaged neurons. RL J. Biol. Chem. 283:6988-6996 (2008). RN [158]; RE0065201. RX PUBMED: 17703191. RA Shembade N., Harhaj N. S., Liebl D. J., Harhaj E. W. RT Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling. RL EMBO J. 26:3910-3922 (2007). RN [159]; RE0065477. RX PUBMED: 18354174. RA Valledor A. F., Sanchez-Tillo E., Arpa L., Park J. M., Caelles C., LLoberas J., Celada A. RT Selective roles of MAPKs during the macrophage response to IFN-gamma. RL J. Immunol. 180:4523-4529 (2008). RN [160]; RE0065835. RX PUBMED: 10700460. RA Labuda T., Sundstedt A., Dohlsten M. RT Selective induction of p38 mitogen-activated protein kinase activity following A6H co-stimulation in primary human CD4(+) T cells. RL Int. Immunol. 12:253-261 (2000). RN [161]; RE0066089. RX PUBMED: 20042607. RA Zhang R., Chen H. Z., Liu J. J., Jia Y. Y., Zhang Z. Q., Yang R. F., Zhang Y., Xu J., Wei Y. S., Liu D. P., Liang C. C. RT SIRT1 Suppresses Activator Protein-1 Transcriptional Activity and Cyclooxygenase-2 Expression in Macrophages. RL J. Biol. Chem. 285:7097-7110 (2010). RN [162]; RE0066275. RX PUBMED: 20028971. RA Bi W., Xiao L., Jia Y., Wu J., Xie Q., Ren J., Ji G., Yuan Z. RT c-Jun N-terminal kinase enhances MST1-mediated pro-apoptotic signaling through phosphorylation at serine 82. RL J. Biol. Chem. 285:6259-6264 (2010). RN [163]; RE0066281. RX PUBMED: 9447970. RA Itoh T., Liu R., Yokota T., Arai K. I., Watanabe S. RT Definition of the role of tyrosine residues of the common beta subunit regulating multiple signaling pathways of granulocyte-macrophage colony-stimulating factor receptor. RL Mol. Cell. Biol. 18:742-752 (1998). RN [164]; RE0067161. RX PUBMED: 19805025. RA Yoon K. W., Cho J. H., Lee J. K., Kang Y. H., Chae J. S., Kim Y. M., Kim J., Kim E. K., Kim S. E., Baik J. H., Naik U. P., Cho S. G., Choi E. J. RT CIB1 functions as a Ca(2+)-sensitive modulator of stress-induced signaling by targeting ASK1. RL Proc. Natl. Acad. Sci. USA 106:17389-17394 (2009). RN [165]; RE0067215. RX PUBMED: 16055701. RA Han J., Shui J. W., Zhang X., Zheng B., Han S., Tan T. H. RT HIP-55 is important for T-cell proliferation, cytokine production, and immune responses. RL Mol. Cell. Biol. 25:6869-6878 (2005). RN [166]; RE0067525. RX PUBMED: 16407264. RA He Y., Zhang W., Zhang R., Zhang H., Min W. RT SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation. RL J. Biol. Chem. 281:5559-5566 (2006). RN [167]; RE0067621. RX PUBMED: 16291755. RA Eliopoulos A. G., Das S., Tsichlis P. N. RT The tyrosine kinase Syk regulates TPL2 activation signals. RL J. Biol. Chem. 281:1371-1380 (2006). RN [168]; RE0068102. RX PUBMED: 11313918. RA Ma W., Xia C., Ling P., Qiu M., Luo Y., Tan T. H., Liu M. RT Leukocyte-specific adaptor protein Grap2 interacts with hematopoietic progenitor kinase 1 (HPK1) to activate JNK signaling pathway in T lymphocytes. RL Oncogene 20:1703-1714 (2001). RN [169]; RE0068697. RX PUBMED: 12093866. RA Haks M. C., Pepin E., van den Brakel J. H., Smeele S. A., Belkowski S. M., Kessels H. W., Krimpenfort P., Kruisbeek A. M. RT Contributions of the T cell receptor-associated CD3gamma-ITAM to thymocyte selection. RL J. Exp. Med. 196:1-13 (2002). RN [170]; RE0068789. RX PUBMED: 17189706. RA Blonska M., Pappu B. P., Matsumoto R., Li H., Su B., Wang D., Lin X. RT The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway. RL Immunity 26:55-66 (2007). RN [171]; RE0070404. RX PUBMED: 20516211. RA Da Costa C. R., Villadiego J., Sancho R., Fontana X., Packham G., Nateri A. S., Behrens A. RT Bag1-L is a phosphorylation-dependent coactivator of c-Jun during neuronal apoptosis. RL Mol. Cell. Biol. 30:3842-3852 (2010). RN [172]; RE0070509. RX PUBMED: 21119000. RA Zhang L., Blackwell K., Altaeva A., Shi Z., Habelhah H. RT TRAF2 phosphorylation promotes NF-kappaB-dependent gene expression and inhibits oxidative stress-induced cell death. RL Mol. Biol. Cell 22:128-140 (2011). RN [173]; RE0071284. RX PUBMED: 12198159. RA Abassi Y. A., Vuori K. RT Tyrosine 221 in Crk regulates adhesion-dependent membrane localization of Crk and Rac and activation of Rac signaling. RL EMBO J. 21:4571-4582 (2002). RN [174]; RE0072505. RX PUBMED: 19433446. RA Morel C., Carlson S. M., White F. M., Davis R. J. RT Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis. RL Mol. Cell. Biol. 29:3845-3852 (2009). XX //